LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction

PHASE2CompletedINTERVENTIONAL
Enrollment

307

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Chronic Heart Failure
Interventions
DRUG

LCZ696

50 mg, 100 mg and 200 mg tablets

DRUG

Valsartan

40 mg, 80 mg and 160 mg tablets

DRUG

Placebo

matching placebo to LCZ696 and Valsartan

Trial Locations (81)

1010

Novartis Investigative Site, Caracas

3000

Novartis Investigative Site, Santa Fe

4011

Novartis Investigative Site, Maracaibo

15006

Novartis Investigative Site, A Coruña

15706

Novartis Investigative Site, Santiago de Compostela

19038

Novartis Investigative Site, Sarzana

19610

Novartis Investigative Site, Wyomissing

21019

Novartis Investigative Site, Somma Lombardo

24128

Novartis Investigative Site, Bergamo

27022

Novartis Investigative Site, Casorate Primo

28034

Novartis Investigative Site, Madrid

28046

Novartis Investigative Site, Madrid

33038

Novartis Investigative Site, San Daniele del Friuli

37203

Novartis Investigative Site, Nashville

41009

Novartis Investigative Site, Seville

48201

Novartis Investigative Site, Detroit

56124

Novartis Investigative Site, Pisa

60657

Novartis Investigative Site, Chicago

68506

Novartis Investigative Site, Lincoln

68803

Novartis Investigative Site, Grand Island

72205

Novartis Investigative Site, Little Rock

73120

Novartis Investigative Site, Oklahoma City

74133

Novartis Investigative Site, Tulsa

77025

Novartis Investigative Site, Houston

87100

Novartis Investigative Site, Cosenza

97123

Novartis Investigative Site, Hillsboro

110060

Novartis Investigative Site, New Delhi

110114

Novartis Investigative Site, Piteşti

117292

Novartis Investigative Site, Moscow

119074

Novartis Investigative Site, Singapore

121552

Novartis Investigative Site, Moscow

169609

Novartis Investigative Site, Singapore

194044

Novartis Investigative Site, Saint Petersburg

196247

Novartis Investigative Site, S.-Petersburg

197341

Novartis Investigative Site, Saint Petersburg

200147

Novartis Investigative Site, Craiova

200235

Novartis Investigative Site, Craiova

302001

Novartis Investigative Site, Jaipur

302004

Novartis Investigative Site, Jaipur

430031

Novartis Investigative Site, Baia Mare

440012

Novartis Investigative Site, Nagpur

500012

Novartis Investigative Site, Hyderabad

500034

Novartis Investigative Site, Hyderabad

575002

Novartis Investigative Site, Mangalore

576104

Novartis Investigative Site, Manipal

44000033

Novartis Investigative Site, Nagpur

C1408INH

Novartis Investigative Site, Caba

C1119ACN

Novartis Investigative Site, Ciudad Autonoma de Bs As

B1704ETD

Novartis Investigative Site, Ramos Mejía

B1650CSQ

Novartis Investigative Site, San Martín

W3400

Novartis Investigative Site, Corrientes

X5000EPU

Novartis Investigative Site, Córdoba

X5000EVQ

Novartis Investigative Site, Córdoba

S200CVD

Novartis Investigative Site, Rosario

S3000FWO

Novartis Investigative Site, Santa Fe

T4000EBR

Novartis Investigative Site, San Miguel de Tucumán

74605-050

Novartis Investigative Site, Goiânia

90610-000

Novartis Investigative Site, Porto Alegre

15015-750

Novartis Investigative Site, São José do Rio Preto

05403-000

Novartis Investigative Site, São Paulo

L6Z 4N5

Novartis Investigative Site, Brampton

H3A 1A1

Novartis Investigative Site, Montreal

H3G 1A4

Novartis Investigative Site, Montreal

D-37075

Novartis Investigative Site, Göttingen

400 022

Novartis Investigative Site, Mumbai

500 063

Novartis Investigative Site, Hyderabad

6716 RP

Novartis Investigative Site, Ede

1105 AZ

Novartis Investigative Site, Amsterdam

NL 2625 AD

Novartis Investigative Site, Delft

4462 RA

Novartis Investigative Site, Goes

9713 GZ

Novartis Investigative Site, Groningen

8441 PW

Novartis Investigative Site, Heerenveen

6419 PC

Novartis Investigative Site, Heerlen

7555 DL

Novartis Investigative Site, Hengelo

04-761

Novartis Investigative Site, Warszawa/Anin

97-300

Novartis Investigative Site, Piotrkow Trybunalski

98-200

Novartis Investigative Site, Sieradz

50-981

Novartis Investigative Site, Wroclaw

51-124

Novartis Investigative Site, Wroclaw

08907

Novartis Investigative Site, L'Hospitalet de Llobregat

03004

Novartis Investigative Site, Alicante

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY